Peer-Review Record
Interdependent Impact of Lipoprotein Receptors and Lipid-Lowering Drugs on HCV Infectivity
Cells 2021, 10(7), 1626; https://doi.org/10.3390/cells10071626
by
Francisco J. Zapatero-Belinchón 1,2,3,4,5,6,7,†
, Rina Ötjengerdes 1,2,3,4,†, Julie Sheldon 1, Benjamin Schulte 2,4, Belén Carriquí-Madroñal 1,7, Graham Brogden 1,7, Laura M. Arroyo-Fernández 7, Florian W. R. Vondran 4,8, Benjamin Maasoumy 2,4, Thomas von Hahn 2,9,*,‡ and Gisa Gerold 1,5,6,7,*,‡
, Rina Ötjengerdes 1,2,3,4,†, Julie Sheldon 1, Benjamin Schulte 2,4, Belén Carriquí-Madroñal 1,7, Graham Brogden 1,7, Laura M. Arroyo-Fernández 7, Florian W. R. Vondran 4,8, Benjamin Maasoumy 2,4, Thomas von Hahn 2,9,*,‡ and Gisa Gerold 1,5,6,7,*,‡Reviewer 1:
Anonymous
Reviewer 2:
Anonymous
Cells 2021, 10(7), 1626; https://doi.org/10.3390/cells10071626
Submission received: 28 May 2021
/
Accepted: 25 June 2021
/
Published: 29 June 2021
(This article belongs to the Special Issue Cell Biology of Viral Infections)
Round 1
Reviewer 1 Report
no comment
Reviewer 2 Report
I would like to thank you authors for their extensive revisions and clear description of the edits made. I am happy to see this article published without further revision.
